← Back to all trials
Active Not Recruiting
NCT05464823
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
Conditions: Lymphoma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 111
Sponsor: M.D. Anderson Cancer Center
Location: M D Anderson Cancer Center Houston Texas
Summary
To learn more about the usefulness of molecular testing with the Molecular Functional (MF) Portrait (a commercial test conducted by the sponsor of this study, BostonGene) in guiding lymphoma care.
Eligibility Criteria
Patient Eligibility:
Inclusion Criteria:
1. Male/female patients who are at least 18 years of age on the day of informed consent signing.
2. Patients must have a histologically documented diffuse large B-cell lymphoma requiring therapy.
3. Provision of written informed consent for the study.
Exclusion Criteria:
1\. None
Source: ClinicalTrials.gov (NCT05464823). StuddyBuddy aggregates publicly available trial information.
